ArticleCanadian journal of kidney health and disease2024
Single Center Experience With Sodium-Glucose Co-Transporter-2 Inhibitors (SGLT2i) in Kidney Transplant Recipients With Diabetes.
Albi Angjeli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.